Investment in early-stage medtech innovation can be critical in ensuring that patients have access to novel therapeutics and diagnostics.
Medical devices can offer important therapeutic advances but, as for any medical interventions, there are questions about their costs and benefits.
This report provides a 2021 statistical update on the contributions of the medical technology industry to national and state economic conditions.
To understand where medtech companies stand in fulfilling this objective, Deloitte and AdvaMed conducted a benchmarking analysis of data from 20 medtech company business units.
This study was engaged to develop estimates of medical device spending in the United States, compare our estimates to NHE estimates published by CMS, and develop estimates of price changes…
Listen to AdvaMed's Podcast
Brought to you by AdvaMed, MedTech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
This study aimed to verify whether the medical technology available in the Brazilian market is, in fact, becoming more expensive and increasing healthcare costs.
This report focuses on ways to modernize Medicare’s payment and coverage policies.
The objective of this study is to assess the potential impact of pricing regulation of medical devices in Brazil, China, Colombia and India.
Use Case: Application Of The Medtech Value Assessment Framework To Ophthalmic Devices Used In The Correction And Treatment Of Myopia
This use case discusses utilization of these technologies in managing myopia, including correction of myopic refractive error and controlling the progression of myopia across patient populations.